Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Apuli Maricel. Insider active across 1 company, notably BridgeBio Pharma, Inc.. In total, 13 reports have been published. Split: 0 buy · 5 sells. Total volume traded: €453k. History available since 19 March 2025. The latest transaction was filed on 16 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Apuli Maricel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
4,714 shares@ US$79.86Common StockSEC:0001470831-26-000835:0
2,000 shares@ US$80.060.0010% mcap9.4% of flowCommon StockSEC:0001470831-26-000745:0
14,170 shares0Common StockSEC:0001470831-26-000302:0
2,000 shares@ US$66.008.3% of flowCommon StockSEC:0001470831-26-000225:0
4,349 shares@ US$75.2520.5% of flowCommon StockSEC:0001470831-26-000186:0
2,003 shares@ US$75.1516.2% of flowCommon StockSEC:0001470831-25-000418:0
2,000 shares@ US$74.2613.3% of flowCommon StockSEC:0001470831-25-000392:0
4,781 shares@ US$66.3934.5% of flowCommon StockSEC:0001470831-25-000349:0
4,781 shares@ US$51.3226.6% of flowCommon StockSEC:0000950170-25-110276:0
1,000 shares@ US$45.444.7% of flowCommon StockSEC:0000950170-25-106751:0
4,780 shares@ US$33.8418.3% of flowCommon StockSEC:0000950170-25-075340:0
1,026 shares@ US$38.50794.4% of flowCommon StockSEC:0000950170-25-064567:0
23,660 shares0Common StockSEC:0000950170-25-043376:0
About Apuli Maricel
Apuli Maricel is a declarant associated with BridgeBio Pharma, Inc., where the listed role is Chief Accounting Officer. There are 12 filings in total, and across the 12 sampled filings between 2025-03-21 and 2026-08-03, sell volume totals EUR 452908 and the modal transaction nature is Sale.